Primary Analysis of MUKDEN 01: A Multicenter, Single-Arm, Prospective, Phase 2 Study of Neoadjuvant Treatment with Pyrotinib and Letrozole Plus Dalpiciclib in Triple-Positive Breast Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined